COF had much lower provisions, but still missed on a adjusted basis. Still expected stock buybacks should boost Stock as we move to a Buy. Still Sell on benchmark bonds. Systemic risk moves to Very Low and counterparty risk to Low.
Regions beat estimates, but had very unimpressive results relying on reserve releases as a non-core boost.. Remain a Sell on Stock & benchmark Bonds. Very Low systemic risk and Medium counterparty risk.
Truist beats consensus but is challenged to complete its merger integration given Covid constraints. Investment banking and insurance were the drivers. Sell on Stock & benchmark Bonds. Systemic risk Very Low. Counterparty risk Low.
USB takes a more conservative reserve stance as only regional not to reslease. Looking for gradual economic pickup for earnings growth and to lift its payments business. On the stock buyback trail as well. Buy Stock, Sell benchmark bonds. Systemic risk is Very Low and counterparty risk Low.
Key had a record revenues year driven by investment banking and consumer mortgage and fintech generated consumer loans. With attractive financial metrics we move to a Buy on the Stock. Still a Sell on rich benchmark bonds. Sytemic risk Low. Counterparty risk Low-to-Medium.
Fifth Third seems to have run out of gas as it lacks growth drivers and is reliant on macro forces for potetential revenues lift. Remain a Sell on the stock and Sell on benchmark bonds. Sytemic and counterparty risks are Low.
Morgan Stanley enjoyed the 4Q20 windfall in equity underwriting and trading as it further integrates its major acquisitions: E*TRADE (closed) and Eaton Vance (closing in 2Q21). Much more sustainability of earnings given external and internal moves. Buy Stock, Sell on benchmark bonds. Systemic risk Very Low, Counterparty risk Low.
CFG seems to be in another optimistic world of economic rebound, buybacks and being a buyer in the M&A world. We are more pessimistic and are a Sell on Stock and benchmark bonds. Systemic risk is low and counterparty risk is Low-to-Medium.
Goldman Sachs had an explosive 4Q20 as its equities machine pumped out windfall gains in underwriting and trading. Still, it made good progress on its strategic targets. We move to Buy on Stock, maintain Sell on benchmark bonds. Systemic and counterparty risk is Medium.
BAC has lots of deposit powder to put to work as it waits for higher rates, a steeper yield curve, and economic recovery. Leans on stock buybacks to keep stock going. Buy Stock, Sell on benchmark bonds, Low systemic risk. Counterparty risk Medium.